Trinity Biotech PLC (TRIB)
1.30
0.00 (0.00%)
USD |
NASDAQ |
Nov 21, 16:00
1.30
0.00 (0.00%)
After-Hours: 07:39
Trinity Biotech Profit Margin (Quarterly): -31.41% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -31.41% |
| June 30, 2024 | -42.65% |
| March 31, 2024 | -22.56% |
| December 31, 2023 | -40.97% |
| September 30, 2023 | -45.79% |
| June 30, 2023 | -43.09% |
| March 31, 2023 | -39.17% |
| December 31, 2022 | -64.09% |
| September 30, 2022 | -56.96% |
| June 30, 2022 | -62.96% |
| March 31, 2022 | -78.33% |
| December 31, 2021 | -16.41% |
| September 30, 2021 | 6.00% |
| June 30, 2021 | -3.03% |
| March 31, 2021 | 6.26% |
| December 31, 2020 | -30.59% |
| September 30, 2020 | 22.88% |
| June 30, 2020 | -9.16% |
| March 31, 2020 | -10.49% |
| December 31, 2019 | -109.4% |
| September 30, 2019 | 0.10% |
| June 30, 2019 | -24.03% |
| March 31, 2019 | -0.96% |
| December 31, 2018 | -97.70% |
| September 30, 2018 | 3.78% |
| Date | Value |
|---|---|
| June 30, 2018 | 2.38% |
| March 31, 2018 | 1.59% |
| December 31, 2017 | -174.6% |
| September 30, 2017 | 1.74% |
| June 30, 2017 | 3.54% |
| March 31, 2017 | 5.29% |
| December 31, 2016 | -425.9% |
| September 30, 2016 | -1.98% |
| June 30, 2016 | 8.00% |
| March 31, 2016 | -5.73% |
| December 31, 2015 | 11.33% |
| September 30, 2015 | 47.60% |
| June 30, 2015 | 11.11% |
| March 31, 2015 | 15.88% |
| December 31, 2014 | 15.46% |
| September 30, 2014 | 16.06% |
| June 30, 2014 | 16.59% |
| March 31, 2014 | 17.63% |
| December 31, 2013 | 18.22% |
| September 30, 2013 | -12.39% |
| June 30, 2013 | 17.96% |
| March 31, 2013 | 20.50% |
| December 31, 2012 | 21.46% |
| September 30, 2012 | 21.39% |
| June 30, 2012 | 20.67% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-109.4%
Minimum
Dec 2019
22.88%
Maximum
Sep 2020
-33.60%
Average
-35.29%
Median
Profit Margin (Quarterly) Benchmarks
| Amarin Corp PLC | -59.42% |
| DBV Technologies SA | -- |
| Ascendis Pharma AS | -171.5% |
| Cellectis SA | -142.3% |
| Adaptimmune Therapeutics PLC | -43.07% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -25.10% |
| Return on Invested Capital | -45.03% |
| Gross Profit Margin (Quarterly) | 35.03% |
| Operating Margin (Quarterly) | -14.64% |
| Return on Net Operating Assets | -27.11% |